NEW YORK–(COMMERCIAL THREAD) –BTIG announced today that Mark Massaro has joined the company’s health research team as managing director and analyst of life sciences and diagnostic tools. Mr. Massaro will be based in BTIG’s Boston office and will report to David Lenchus, Research Director, at BTIG.
Prior to BTIG, Mr. Massaro served as Chief Financial Officer at ArcherDX, Inc., an cancer diagnostics and pharmaceutical services company. Previously, he was Managing Director and Senior Equity Research Analyst in Diagnostics and Life Science Tools at Canaccord Genuity, where he spent more than eight years focusing on precision medicine and new sequencing companies. high growth generation, as well as molecular and ad hoc societies. -diagnosis of care, reference laboratories and animal health. Mr. Massaro was named a “Rising Star” in Institutional Investor’s All America Survey for Life Sciences and Diagnostic Tools in October 2016. Earlier in his career, he was an Associate Equity Analyst at Health Services at Avondale Partners and has held corporate finance and financial reporting roles. positions at Dell EMC and Fidelity Investments. Mr. Massaro holds an MBA from Babson College and a BA in Economics and Spanish from the University of Massachusetts – Amherst.
“We are delighted to add Mark to the research and strategy team,” said Mr. Lenchus. “Based on his corporate leadership experience and over a decade as an analyst in life sciences and sales-side diagnostic tools, we believe he will bring an important perspective to clients when they will assess their investments and the health care market. ”
Along with Mr. Massaro, BTIG will now have two research analysts exclusively focused on the life sciences and diagnostic tools vertical within the company, where Sung Ji Nam covers space since 2017. Other health analysts in the BTIG publication include Biotechnology analysts Bert Hazlett, Thomas Shrader, PhD, CFA, Dae Gon Ha, PhD, and Julien harrison, Medical technology and digital health analyst Marie Thibault, and Medical technology analyst Ryan zimmerman.
BTIG Research and Strategy provides comprehensive reports, industry observations, and other information to clients. The team’s sector focus includes consumer, energy, finance, healthcare, real estate, shipping and technology, media and telecommunications. Visit www.btigresearch.com to learn more.
BTIG is a global financial services company specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global presence and more than 600 employees, BTIG, LLC and its subsidiaries operate in 18 cities in the United States, Europe, Asia and Australia. BTIG offers execution, expertise and knowledge for equities, equity derivatives, ETFs and fixed income securities, currencies and commodities (futures, commodities, foreign exchange, interest rate, credit and convertible and privileged securities). The company’s core capabilities include global execution, portfolio, electronic and outsourced trading, transition management, investment banking, blue chip brokerage, capital introduction, access to companies, research and strategy, commission management, etc.
Disclaimer: https://www.btig.com/disclaimer. To learn more about BTIG, visit www.btig.com.